Blinded analysis confirmed that both the proportion of IL-8+ naïve CD4+ T cells and the proportion of IL-8+ naïve CD8+ T cells were markedly elevated in patients with thymomas, compared to healthy controls or patients with thymic cysts, teratomas, and lymphomas in the validation set (Fig. 1c, d). This evidence concerns the gene CXCL8 and lymphoma.